IFNA1 and Miyoshi myopathy: Although IFNα was investigated as a therapeutic molecule in early myeloma treatment trials [41], it was shown that co-cultures with IFNα-producing plasmacytoid DCs demonstrated higher plasma and MM cell proliferation [42,43].